查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1518362

藥物發現中的人工智慧市場：依產品、應用、治療領域、部署和最終用戶劃分 - 到 2030 年的全球預測

Artificial Intelligence in Drug Discovery Market by Offering (Software, Service), Application (Target Discovery, Lead Identification, Clinical Testing), Therapy Area (Oncology, Cardiology, Neurodegenerative), Deployment, End User-Global Forecast to 2030
出版日期: | 出版商: Meticulous Research | 英文 200 Pages | 商品交期: 5-7個工作天內

價格

預計到 2030 年，全球人工智慧在藥物發現市場將達到 89.5 億美元，2023 年至 2030 年複合年增長率為 27.2%。

該報告在廣泛的二級和一級研究以及對市場情景的詳細分析後，對關鍵行業驅動因素、抑制因素、課題和機會進行了分析。

這一市場成長的驅動因素包括人們越來越關注縮短藥物發現的周轉時間、藥物發現中人工智慧新興市場的擴大、慢性病患病率的上升以及藥物發現和市場開發進程的加快。夥伴關係。將人工智慧納入藥物發現的資源限制是該領域市場擴張的主要障礙。

此外，新興經濟體的成長和研發投資的增加預計將為該市場的利害關係人創造利潤豐厚的機會。然而，有限的可用數據集是影響市場成長的主要課題。

目錄

第1章 簡介

第2章 研究方法

  • 調查先決條件
  • 研究局限性

第3章 執行概述

第4章 市場洞察

  • 介紹
  • 促進因素
    • 越來越關注縮短藥物發現所需的時間
    • 擴大人工智慧在藥物發現的應用
    • 慢性病增加
    • 增加研究合作和夥伴關係，以加速藥物發現和開發
  • 抑制因素
    • 將人工智慧整合到藥物發現的資源有限
  • 機會
    • 新興經濟體
    • 加大研發投入
  • 任務
    • 數據集的可用性有限
  • COVID-19 對藥物發現人工智慧市場的影響

第5章 藥物發現中人工智慧的全球市場：依產品分類

  • 介紹
  • 軟件
  • 服務

第6章 藥物發現中人工智慧的全球市場：依發展劃分

  • 介紹
  • 雲端和網路為基礎的模式
  • 本地部署模式

第7章 藥物發現中人工智慧的全球市場：依應用分類

  • 介紹
  • 目標探索和驗證
  • 先導化合物的鑑定
  • 從頭設計和藥物優化
  • 臨床前和臨床試驗

第8章 藥物發現中人工智慧的全球市場：依治療領域

  • 介紹
  • 癌症領域
  • 神經退行性疾病
  • 心血管疾病
  • 代謝性疾病
  • 其他

第9章 藥物發現中人工智慧的全球市場：依最終用戶劃分

  • 介紹
  • 製藥和生物技術公司
  • 合約藥物開發組織（CRO）
  • 學術/研究機構

第10章 藥物發現中的人工智慧市場：依地區

  • 介紹
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 亞太其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他拉丁美洲
  • 中東/非洲

第11章 競爭格局

  • 介紹
  • 主要成長策略
  • 競爭標桿
  • 市場佔有率分析（2022 年）

第12章 公司簡介（業務概況、財務概況、解決方案組合、策略發展）

  • Microsoft Corporation
  • Exscientia plc
  • NVIDIA Corporation
  • Schrodinger, LLC
  • Atomwise, Inc.
  • BenevolentAI Limited
  • Deep Genomics Incorporated
  • InSilico Medicine
  • Cloud Pharmaceuticals, Inc.
  • Standigm Inc.

第13章 附錄

Product Code: MRHC - 104745

Artificial Intelligence in Drug Discovery Market Size, Share, Forecast, & Trends Analysis by Offering (Software, Service), Application (Target Discovery, Testing), Therapy Area (Oncology, Cardiology), Deployment, End User-Global Forecast to 2030

The global artificial intelligence in drug discovery market is projected to reach $8.95 billion by 2030 at a CAGR of 27.2% from 2023 to 2030.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities.

The growth of this market can be attributed to the rising focus on reducing turnaround time in drug discovery, growing applications of AI in drug discovery, rising prevalence of chronic diseases, and rising collaborations & partnerships to accelerate the process of drug discovery and development. The constrained resource availability for integrating AI into drug discovery poses a significant impediment to market expansion in this sector.

Moreover, the growth of emerging economies and increased investments in research & development are anticipated to create lucrative opportunities for stakeholders in this market. However, limited availability of data sets are major challenges impacting market growth.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over four years (2020-2023). The key players operating in the global artificial intelligence in drug discovery market are Microsoft Corporation (U.S.), Exscientia plc (U.K.), NVIDIA Corporation (U.S.), Schrodinger, LLC (U.S.), Atomwise, Inc. (U.S.), BenevolentAI Limited (U.K.), Deep Genomics Incorporated (Canada), InSilico Medicine (U.S.), Cloud Pharmaceuticals, Inc. (U.S.), and Standigm Inc. (South Korea).

Among all the offerings studied in this report, in 2023, the software segment is expected to account for the largest share of the AI in drug discovery market. AI in drug discovery software is used for faster, efficient, and cost-effective drug discovery and enhanced clinical trials. Thus, the growing interest of pharmaceutical companies in developing novel therapies has increased the adoption of AI in drug discovery software.

Among all the deployment modes studied in this report, the cloud-based segment is projected to register the highest CAGR over the forecast period. The demand for cloud-based and web-based platforms is growing due to the benefits of cloud-based models in terms of security, flexibility, high-capacity data storage, quick accessibility, and cost-effectiveness.

Among all the therapeutic areas studied in this report, in 2023, the oncology segment is expected to account for the largest share of the global AI in drug discovery market. Numerous collaborations between drug discovery and AI companies are bolstering the significant market share of this segment. For instance, in November 2022, The University of Texas MD Anderson Cancer Center (U.S.) and Exscientia plc (U.K.) entered a strategic collaboration to combine the drug discovery & development expertise of MD Anderson with the patient-centric artificial intelligence (AI) capabilities of Exscientia, to boost the development of novel small-molecule oncology therapies. Additionally, in November 2021, Sanofi (France) announced an equity investment of USD 180 million in Owkin (U.S.), an AI and precision medicine company, aimed at advancing its oncology pipeline.

Among all the applications studied in this report, in 2023, the lead compound identification segment is expected to account for the largest share of the global AI in drug discovery market. Identifying lead compounds is a pivotal stage in drug discovery, where crucial properties like selectivity and potency are determined before advancing to clinical studies. Integrating AI can streamline pre-clinical development timelines, optimizing resource allocation effectively. Therefore, the utilization of AI in this phase of drug discovery is pivotal, contributing significantly to the large market share of this sector.

Among all end users studied in this report, in 2023, the pharmaceutical & biopharmaceutical companies segment is expected to account for the largest share of the global AI in drug discovery market. The high prevalence of chronic and infectious diseases, high pressure on the pharmaceutical, and biotechnology companies, to bring effective therapies early to the market, and combined benefits of AI algorithms in facilitating smooth drug discovery processes are key factors contributing to the significant market share of this segment.

An in-depth analysis of the geographical scenario of the global artificial intelligence in drug discovery market provides detailed qualitative and quantitative insights into the five major regions (North America, Europe, Asia-Pacific, Latin America, and the Middle-East & Africa), along with the coverage of major countries in each region. In 2023, North America is expected to account for the largest share of the artificial intelligence in drug discovery market. In North America, in 2023, the U.S. is expected to account for the largest share of the artificial intelligence in drug discovery market. The large share of this regional market is attributed to increasing public and private investments in drug discovery, and the high adoption of AI solutions in drug discovery. The presence of key AI companies and pharmaceutical companies such as Abbott Laboratories (U.S) and Pfizer Inc. (U.S) also support the large share of this market.

Scope of the Report:

Artificial Intelligence in Drug Discovery Market Assessment-by Offering

  • Software
  • Services

Artificial Intelligence in Drug Discovery Market Assessment-by Deployment Mode

  • On-premises
  • Cloud & Web-based Mode

Artificial Intelligence in Drug Discovery Market Assessment-by Application

  • Target Discovery & Validation
  • Lead Compound Identification
  • De Novo Design and Drug Optimization
  • Preclinical & Clinical Testing

Artificial Intelligence in Drug Discovery Market Assessment-by Therapeutic Area

  • Oncology
  • Neurodegenerative Diseases
  • Cardiovascular Diseases
  • Metabolic Diseases
  • Other Therapeutic Areas

Note: Other therapeutic areas include infectious diseases and rare diseases.

Artificial Intelligence in Drug Discovery Market Assessment-by End Users

  • Pharmaceutical & Biopharmaceutical Companies
  • Contract Research Organizations (CROs)
  • Academic & Research Institutes

Artificial intelligence in Drug Discovery Market Assessment-by Geography

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • Rest of Asia-Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle-East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Ecosystem
  • 1.3. Currency
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Process
  • 2.2. Data Collection & Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research
  • 2.3. Market Assessment
    • 2.3.1. Market Size Estimation
      • 2.3.1.1. Bottom-up Approach
      • 2.3.1.2. Top-down Approach
      • 2.3.1.3. Growth Forecast
    • 2.3.2. Market Share Analysis
  • 2.4. Assumptions for the Study
  • 2.5. Limitations for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Introduction
  • 4.2. Drivers
    • 4.2.1. Rising Focus on Reducing Turnaround Time in Drug Discovery
    • 4.2.2. Growing Applications of AI in Drug Discovery
    • 4.2.3. Rising Incidences of Chronic Diseases
    • 4.2.4. Rising Collaborations and Partnerships to Accelerate the Drug Discovery and Development
  • 4.3. Restraints
    • 4.3.1. Limited Availability of Resources for Integration of AI in Drug Discovery
  • 4.4. Opportunity
    • 4.4.1. Emerging Economies
    • 4.4.2. Rise in the Investments for R&D
  • 4.5. Challenges
    • 4.5.1. Limited Availability of Data Setss
  • 4.6. Impact of COVID-19 on the AI in Drug Discovery Market

5. Global AI in Drug Discovery Market, by Offering

  • 5.1. Introduction
  • 5.2. Software
  • 5.3. Services

6. Global AI in Drug Discovery Market, by Deployment Mode

  • 6.1. Introduction
  • 6.2. Cloud & Web-based Mode
  • 6.3. On-premises Mode

7. Global AI in Drug Discovery Market, by Application

  • 7.1. Introduction
  • 7.2. Target Discovery & Validation
  • 7.3. Lead Compound Identification
  • 7.4. De Novo Design & Drug Optimization
  • 7.5. Preclinical & Clinical Testing

8. Global AI in Drug Discovery Market, by Therapeutic Area

  • 8.1. Introduction
  • 8.2. Oncology
  • 8.3. Neurodegenerative Diseases
  • 8.4. Cardiovascular Diseases
  • 8.5. Metabolic Diseases
  • 8.6. Other Therapeutic Areas

9. Global AI in Drug Discovery Market, by End User

  • 9.1. Introduction
  • 9.2. Pharmaceutical & Biotechnology Companies
  • 9.3. Contract Research Organizations (CROs)
  • 9.4. Academic & Research Institutes

10. AI in Drug Discovery Market, by Geography

  • 10.1. Introduction
  • 10.2. North America
    • 10.2.1. U. S.
    • 10.2.2. Canada
  • 10.3. Europe
    • 10.3.1. Germany
    • 10.3.2. France
    • 10.3.3. U.K.
    • 10.3.4. Italy
    • 10.3.5. Spain
    • 10.3.6. Rest of Europe
  • 10.4. Asia-Pacific
    • 10.4.1. China
    • 10.4.2. Japan
    • 10.4.3. India
    • 10.4.4. Rest of Asia-Pacific
  • 10.5. Latin America
    • 10.5.1. Brazil
    • 10.5.2. Mexico
    • 10.5.3. Rest of Latin America
  • 10.6. Middle East & Africa

11. Competitive Landscape

  • 11.1. Introduction
  • 11.2. Key Growth Strategies
  • 11.3. Competitive Benchmarking
  • 11.4. Market Share Analysis (2022)

12. Company Profiles (Business Overview, Financial Overview, Solutions Portfolio, and Strategic Developments)

  • 12.1. Microsoft Corporation
  • 12.2. Exscientia plc
  • 12.3. NVIDIA Corporation
  • 12.4. Schrodinger, LLC
  • 12.5. Atomwise, Inc.
  • 12.6. BenevolentAI Limited
  • 12.7. Deep Genomics Incorporated
  • 12.8. InSilico Medicine
  • 12.9. Cloud Pharmaceuticals, Inc.
  • 12.10. Standigm Inc.

13. Appendix

  • 13.1. Questionnaire
  • 13.2. Available Customization

LIST OF TABLES

  • Table 1 Global AI in Drug Discovery Market Drivers: Impact Analysis (2024-2030)
  • Table 2 Global AI in Drug Discovery Market Restraints: Impact Analysis (2024-2030)
  • Table 3 Global AI in Drug Discovery Market Size, by Offering, 2021-2030 (USD Million)
  • Table 4 Global AI in Drug Discovery Software Market Size, by Country/Region, 2021-2030 (USD Million)
  • Table 5 Global AI in Drug Discovery Services Market Size, by Country/Region, 2021-2030 (USD Million)
  • Table 6 Global AI in Drug Discovery Market Size, by Deployment Mode, 2021-2030 (USD Million)
  • Table 7 Global AI in Drug Discovery Market Size for Cloud & Web-Based Mode, by Country/Region, 2021-2030 (USD Million)
  • Table 8 Global AI in Drug Discovery Market Size for On-Premises Mode, by Country/Region, 2021-2030 (USD Million)
  • Table 9 Global AI in Drug Discovery Market Size, by Application, 2021-2030 (USD Million)
  • Table 10 Global AI in Drug Discovery Market Size for Target Discovery & validation, by Country/Region, 2021-2030 (USD Million)
  • Table 11 Global AI in Drug Discovery Market Size for Lead Compound Identification, by Country/Region, 2021-2030 (USD Million)
  • Table 12 Global AI in Drug Discovery Market Size for De Novo Design and Drug Optimization, by Country/Region, 2021-2030 (USD Million)
  • Table 13 Global AI in Drug Discovery Market Size for Preclinical & Clinical Testing, by Country/Region, 2021-2030 (USD Million)
  • Table 14 Global AI in Drug Discovery Market Size, by Therapeutic Area, 2021-2030 (USD Million)
  • Table 15 Global AI in Drug Discovery Market Size for Oncology, by Country/Region, 2021-2030 (USD Million)
  • Table 16 Global AI in Drug Discovery Market Size for Neurodegenerative Diseases, by Country/Region, 2021-2030 (USD Million)
  • Table 17 Global AI in Drug Discovery Market Size for Cardiovascular Diseases, by Country/Region, 2021-2030 (USD Million)
  • Table 18 Global AI in Drug Discovery Market Size for Metabolic Diseases, by Country/Region, 2021-2030 (USD Million)
  • Table 19 Global AI in Drug Discovery Market Size for Other Therapeutic Areas, by Country/Region, 2021-2030 (USD Million)
  • Table 20 Global AI in Drug Discovery Market Size, by End User, 2021-2030 (USD Million)
  • Table 21 Global AI in Drug Discovery Market Size for Pharmaceutical & Biotechnology Companies, by Country/Region, 2021-2030 (USD Million)
  • Table 22 Global AI in Drug Discovery Market Size for Contract Research Organizations (CROs), by Country/Region, 2021-2030 (USD Million)
  • Table 23 Global AI in Drug Discovery Market Size for Academic & Research Institutes, by Country/Region, 2021-2030 (USD Million)
  • Table 24 Global AI in Drug Discovery Market Size, by Country/Region, 2021-2030 (USD Million)
  • Table 25 North America: AI in Drug Discovery Market Size, by Country, 2021-2030 (USD Million)
  • Table 26 North America: AI in Drug Discovery Market Size, by Offering, 2021-2030 (USD Million)
  • Table 27 North America: AI in Drug Discovery Market Size, by Deployment Mode, 2021-2030 (USD Million)
  • Table 28 North America: AI in Drug Discovery Market Size, by Therapeutic Area, 2021-2030 (USD Million)
  • Table 29 North America: AI in Drug Discovery Market Size, by Application, 2021-2030 (USD Million)
  • Table 30 North America: AI in Drug Discovery Market Size, by End User, 2021-2030 (USD Million)
  • Table 31 U.S.: AI in Drug Discovery Market Size, by Offering, 2021-2030 (USD Million)
  • Table 32 U.S.: AI in Drug Discovery Market Size, by Deployment Mode, 2021-2030 (USD Million)
  • Table 33 U.S.: AI in Drug Discovery Market Size, by Therapeutic Area, 2021-2030 (USD Million)
  • Table 34 U.S.: AI in Drug Discovery Market Size, by Application, 2021-2030 (USD Million)
  • Table 35 U.S.: AI in Drug Discovery Market Size, by End User, 2021-2030 (USD Million)
  • Table 36 Canada.: AI in Drug Discovery Market Size, by Offering, 2021-2030 (USD Million)
  • Table 37 Canada: AI in Drug Discovery Market Size, by Deployment Mode, 2021-2030 (USD Million)
  • Table 38 Canada: AI in Drug Discovery Market Size, by Therapeutic Area, 2021-2030 (USD Million)
  • Table 39 Canada: AI in Drug Discovery Market Size, by Application, 2021-2030 (USD Million)
  • Table 40 Canada.: AI in Drug Discovery Market Size, by End User, 2021-2030 (USD Million)
  • Table 41 Europe: AI in Drug Discovery Market Size, by Country/Region, 2024-2030 (USD Million))
  • Table 42 Europe: AI in Drug Discovery Market Size, by Offering, 2021-2030 (USD Million)
  • Table 43 Europe: AI in Drug Discovery Market Size, by Deployment Mode, 2021-2030 (USD Million)
  • Table 44 Europe: AI in Drug Discovery Market Size, by Therapeutic Area, 2021-2030 (USD Million)
  • Table 45 Europe: AI in Drug Discovery Market Size, by Application, 2021-2030 (USD Million)
  • Table 46 Europe: AI in Drug Discovery Market Size, by End User, 2021-2030 (USD Million)
  • Table 47 Germany: AI in Drug Discovery Market Size, by Offering, 2021-2030 (USD Million)
  • Table 48 Germany: AI in Drug Discovery Market Size, by Deployment Mode, 2021-2030 (USD Million)
  • Table 49 Germany: AI in Drug Discovery Market Size, by Therapeutic Area, 2021-2030 (USD Million)
  • Table 50 Germany: AI in Drug Discovery Market Size, by Application, 2021-2030 (USD Million)
  • Table 51 Germany: AI in Drug Discovery Market Size, by End User, 2021-2030 (USD Million)
  • Table 52 France: AI in Drug Discovery Market Size, by Offering, 2021-2030 (USD Million)
  • Table 53 France: AI in Drug Discovery Market Size, by Deployment Mode, 2021-2030 (USD Million)
  • Table 54 France: AI in Drug Discovery Market Size, by Therapeutic Area, 2021-2030 (USD Million)
  • Table 55 France: AI in Drug Discovery Market Size, by Application, 2021-2030 (USD Million)
  • Table 56 France: AI in Drug Discovery Market Size, by End User, 2021-2030 (USD Million)
  • Table 57 U.K.: AI in Drug Discovery Market Size, by Offering, 2021-2030 (USD Million)
  • Table 58 U.K.: AI in Drug Discovery Market Size, by Deployment Mode, 2021-2030 (USD Million)
  • Table 59 U.K.: AI in Drug Discovery Market Size, by Therapeutic Area, 2021-2030 (USD Million)
  • Table 60 U.K.: AI in Drug Discovery Market Size, by Application, 2021-2030 (USD Million)
  • Table 61 U.K.: AI in Drug Discovery Market Size, by End User, 2021-2030 (USD Million)
  • Table 62 Italy: AI in Drug Discovery Market Size, by Offering, 2021-2030 (USD Million)
  • Table 63 Italy: AI in Drug Discovery Market Size, by Deployment Mode, 2021-2030 (USD Million)
  • Table 64 Italy: AI in Drug Discovery Market Size, by Therapeutic Area, 2021-2030 (USD Million)
  • Table 65 Italy: AI in Drug Discovery Market Size, by Application, 2021-2030 (USD Million)
  • Table 66 Italy: AI in Drug Discovery Market Size, by End User, 2021-2030 (USD Million)
  • Table 67 Spain: AI in Drug Discovery Market Size, by Offerings, 2021-2030 (USD Million)
  • Table 68 Spain: AI in Drug Discovery Market Size, by Deployment Mode, 2021-2030 (USD Million)
  • Table 69 Spain: AI in Drug Discovery Market Size, by Therapeutic Area, 2021-2030 (USD Million)
  • Table 70 Spain: AI in Drug Discovery Market Size, by Application, 2021-2030 (USD Million)
  • Table 71 Spain: AI in Drug Discovery Market Size, by End User, 2021-2030 (USD Million)
  • Table 72 Rest of Europe: AI in Drug Discovery Market Size, by Offering, 2021-2030 (USD Million)
  • Table 73 Rest of Europe: AI in Drug Discovery Market Size, by Deployment Mode, 2021-2030 (USD Million)
  • Table 74 Rest of Europe: AI in Drug Discovery Market Size, by Therapeutic Area, 2021-2030 (USD Million)
  • Table 75 Rest of Europe: AI in Drug Discovery Market Size, by Application, 2021-2030 (USD Million)
  • Table 76 Rest of Europe: AI in Drug Discovery Market Size, by End User, 2021-2030 (USD Million)
  • Table 77 Asia-Pacific: AI in Drug Discovery Market Size, by Country/Region, 2021-2030 (USD Million)
  • Table 78 Asia-Pacific: AI in Drug Discovery Market Size, by Offering, 2021-2030 (USD Million)
  • Table 79 Asia-Pacific: AI in Drug Discovery Market Size, by Deployment Mode, 2021-2030 (USD Million)
  • Table 80 Asia-Pacific: AI in Drug Discovery Market Size, by Therapeutic Area, 2021-2030 (USD Million)
  • Table 81 Asia-Pacific: AI in Drug Discovery Market Size, by Application, 2021-2030 (USD Million)
  • Table 82 Asia-Pacific: AI in Drug Discovery Market Size, by End User, 2021-2030 (USD Million)
  • Table 83 China: AI in Drug Discovery Market Size, by Offering, 2021-2030 (USD Million)
  • Table 84 China: AI in Drug Discovery Market Size, by Deployment Mode, 2021-2030 (USD Million)
  • Table 85 China: AI in Drug Discovery Market Size, by Therapeutic Area, 2021-2030 (USD Million)
  • Table 86 China: AI in Drug Discovery Market Size, by Application, 2021-2030 (USD Million)
  • Table 87 China: AI in Drug Discovery Market Size, by End User, 2021-2030 (USD Million)
  • Table 88 Japan: AI in Drug Discovery Market Size, by Offering, 2021-2030 (USD Million)
  • Table 89 Japan: AI in Drug Discovery Market Size, by Deployment Mode, 2021-2030 (USD Million)
  • Table 90 Japan: AI in Drug Discovery Market Size, by Therapeutic Area, 2021-2030 (USD Million)
  • Table 91 Japan: AI in Drug Discovery Market Size, by Application, 2021-2030 (USD Million)
  • Table 92 Japan: AI in Drug Discovery Market Size, by End User, 2021-2030 (USD Million)
  • Table 93 India: AI in Drug Discovery Market Size, by Offering, 2021-2030 (USD Million)
  • Table 94 India: AI in Drug Discovery Market Size, by Deployment Mode, 2021-2030 (USD Million)
  • Table 95 India: AI in Drug Discovery Market Size, by Therapeutic Area, 2021-2030 (USD Million)
  • Table 96 India: AI in Drug Discovery Market Size, by Application, 2021-2030 (USD Million)
  • Table 97 India: AI in Drug Discovery Market Size, by End User, 2021-2030 (USD Million)
  • Table 98 Rest of Asia Pacific: AI in Drug Discovery Market Size, by Offering, 2021-2030 (USD Million)
  • Table 99 Rest of Asia Pacific: AI in Drug Discovery Market Size, by Deployment Mode, 2021-2030 (USD Million)
  • Table 100 Rest of Asia Pacific: AI in Drug Discovery Market Size, by Therapeutic Area, 2021-2030 (USD Million)
  • Table 101 Rest of Asia Pacific: AI in Drug Discovery Market Size, by Application, 2021-2030 (USD Million)
  • Table 102 Rest of Asia Pacific: AI in Drug Discovery Market Size, by End User, 2021-2030 (USD Million)
  • Table 103 Latin America: AI in Drug Discovery Market Size, by Country/Region, 2020-2029 (USD Million)
  • Table 104 Latin America: AI in Drug Discovery Market Size, by Offering, 2021-2030 (USD Million)
  • Table 105 Latin America: AI in Drug Discovery Market Size, by Deployment Mode, 2021-2030 (USD Million)
  • Table 106 Latin America: AI in Drug Discovery Market Size, by Therapeutic Area, 2021-2030 (USD Million)
  • Table 107 Latin America: AI in Drug Discovery Market Size, by Application, 2021-2030 (USD Million)
  • Table 108 Latin America: AI in Drug Discovery Market Size, by End User, 2021-2030 (USD Million)
  • Table 109 Brazil: AI in Drug Discovery Market Size, by Offering, 2021-2030 (USD Million)
  • Table 110 Brazil: AI in Drug Discovery Market Size, by Deployment Mode, 2021-2030 (USD Million)
  • Table 111 Brazil: AI in Drug Discovery Market Size, by Therapeutic Area, 2021-2030 (USD Million)
  • Table 112 Brazil: AI in Drug Discovery Market Size, by Application, 2021-2030 (USD Million)
  • Table 113 Brazil: AI in Drug Discovery Market Size, by End User, 2021-2030 (USD Million)
  • Table 114 Mexico: AI in Drug Discovery Market Size, by Offering, 2021-2030 (USD Million)
  • Table 115 Mexico: AI in Drug Discovery Market Size, by Deployment Mode, 2021-2030 (USD Million)
  • Table 116 Mexico: AI in Drug Discovery Market Size, by Therapeutic Area, 2021-2030 (USD Million)
  • Table 117 Mexico: AI in Drug Discovery Market Size, by Application, 2021-2030 (USD Million)
  • Table 118 Mexico: AI in Drug Discovery Market Size, by End User, 2021-2030 (USD Million)
  • Table 119 Rest of Latin America: AI in Drug Discovery Market Size, by Offering, 2021-2030 (USD Million)
  • Table 120 Rest of Latin America: AI in Drug Discovery Market Size, by Deployment Mode, 2021-2030 (USD Million)
  • Table 121 Rest of Latin America: AI in Drug Discovery Market Size, by Therapeutic Area, 2021-2030 (USD Million)
  • Table 122 Rest of Latin America: AI in Drug Discovery Market Size, by Application, 2021-2030 (USD Million)
  • Table 123 Rest of Latin America: AI in Drug Discovery Market Size, by End User, 2021-2030 (USD Million)
  • Table 124 Middle East & Africa: AI in Drug Discovery Market Size, by Offering, 2021-2030 (USD Million)
  • Table 125 Middle East & Africa: AI in Drug Discovery Market Size, by Deployment Mode, 2021-2030 (USD Million)
  • Table 126 Middle East & Africa: AI in Drug Discovery Market Size, by Therapeutic Area, 2021-2030 (USD Million)
  • Table 127 Middle East & Africa: AI in Drug Discovery Market Size, by Application, 2021-2030 (USD Million)
  • Table 128 Middle East & Africa: AI in Drug Discovery Market Size, by End User, 2021-2030 (USD Million)
  • Table 129 Recent Developments, by Company, 2020-2022

LIST OF FIGURES

  • Figure 1 Research Process
  • Figure 2 Key Secondary Sources
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
  • Figure 6 Market Size Estimation
  • Figure 7 Global AI in Drug Discovery Market Size, by Offering, 2024-2030 (USD Million)
  • Figure 8 Global AI in Drug Discovery Market Size, by Deployment Mode, 2024-2030 (USD Million)
  • Figure 9 Global AI in Drug Discovery Market Size, by Therapeutic Area, 2024-2030 (USD Million)
  • Figure 10 Global AI in Drug Discovery Market Size, by Application, 2024-2030 (USD Million)
  • Figure 11 Global AI in Drug Discovery Market Size, by End User, 2024-2030 (USD Million)
  • Figure 12 Global AI in Drug Discovery Market, by Geography
  • Figure 13 Market Dynamics: AI in Drug Discovery Market
  • Figure 14 Global AI in Drug Discovery Market Size, by Offering, 2024-2030 (USD Million)
  • Figure 15 Global AI in Drug Discovery Market Size, by Deployment Mode, 2024-2030 (USD Million)
  • Figure 16 Global AI in Drug Discovery Market Size, by Therapeutic Area, 2024-2030 (USD Million)
  • Figure 17 Global AI in Drug Discovery Market Size, by Application, 2024-2030 (USD Million)
  • Figure 18 Global AI in Drug Discovery Market Size, by End User, 2024-2030 (USD Million)
  • Figure 19 Global AI in Drug Discovery Market Size, by Geography, 2024-2030 (USD Million)
  • Figure 20 North America: AI in Drug Discovery Market Snapshot
  • Figure 21 Europe: AI in Drug Discovery Market Size Snapshot
  • Figure 22 Asia-Pacific: AI in Drug Discovery Market Size Snapshot
  • Figure 23 Latin America: AI in Drug Discovery Market Size Snapshot
  • Figure 24 Key Growth Strategies Adopted by Leading Players, 2020-2022
  • Figure 25 AI in Drug Discovery Market: Competitive Benchmarking by Offering
  • Figure 26 AI in Drug Discovery Market: Competitive Benchmarking by Geography
  • Figure 27 Market Share Analysis: AI in Drug Discovery Market, 2022
  • Figure 28 Microsoft Corporation: Financial Overview (2021)
  • Figure 29 Exscientia plc: Financial Overview (2021)
  • Figure 30 NVIDIA Corporation: Financial Overview (2021)
  • Figure 31 Schrodinger, LLC: Financial Overview (2021)
  • Figure 32 BenevolentAI Limited: Financial Overview (2021)